Bridgewater Associates’s Burning Rock Biotech BNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,675
Closed -$36.5K 749
2023
Q2
$36.5K Sell
1,675
-4,807
-74% -$105K ﹤0.01% 696
2023
Q1
$182K Sell
6,482
-2,047
-24% -$57.5K ﹤0.01% 703
2022
Q4
$192K Sell
8,529
-143
-2% -$3.22K ﹤0.01% 808
2022
Q3
$207K Sell
8,672
-297
-3% -$7.09K ﹤0.01% 853
2022
Q2
$261K Sell
8,969
-6,872
-43% -$200K ﹤0.01% 956
2022
Q1
$1.47M Sell
15,841
-3,519
-18% -$327K 0.01% 743
2021
Q4
$1.85M Buy
19,360
+3,540
+22% +$337K 0.01% 474
2021
Q3
$2.83M Buy
15,820
+12,424
+366% +$2.22M 0.02% 379
2021
Q2
$1M Buy
+3,396
New +$1M 0.01% 586